Nobuhiro Suzumori

No ORCID on file · 11 papers in corpus · active 1999-2005

Study types

  • article 11

Condition tags

  • endometriosis 10
  • endometrioma 2
article 2005
Increased granulocyte chemotactic protein-2 concentrations in peritoneal fluid of women with endometriosis
·doi:10.1080/j.0001-6349.2005.00680.x

Background. To evaluate the release of granulocyte chemotactic protein-2 (GCP-2) into peritoneal fluid in women with endometriosis, we measured its concentration with reference to the disease stage and the phase of the menstrual cycle. Meth…

article 2005
Increased granulocyte chemotactic protein‐2 concentrations in peritoneal fluid of women with endometriosis
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/j.0001-6349.2005.00680.x

BACKGROUND: To evaluate the release of granulocyte chemotactic protein-2 (GCP-2) into peritoneal fluid in women with endometriosis, we measured its concentration with reference to the disease stage and the phase of the menstrual cycle. METH…

article 2004
Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder
Fertility and Sterility ·doi:10.1016/j.fertnstert.2003.11.043

ObjectiveTo assess the release of angiogenin into peritoneal fluid in women with and without endometriosis by measuring its concentration with reference to disease stage, presence of red lesions, and phase of the menstrual cycle.DesignRetro…

article 2004
Peritoneal fluid concentrations of epithelial neutrophil-activating peptide-78 correlate with the severity of endometriosis
Fertility and Sterility ·doi:10.1016/j.fertnstert.2003.08.011

ObjectiveTo assess the release of epithelial neutrophil-activating peptide-78 (ENA-78) into peritoneal fluid in women with and without endometriosis.DesignRetrospective study.SettingNagoya City University Hospital.Patient(s)Surgery was sche…

article 2004
Women With Endometriosis Have Increased Levels of Placental Growth Factor in the Peritoneal Fluid Compared With Women With Cystadenomas
·doi:10.1097/00006254-200406000-00019

Placental growth factor (PlGF) is a secreted glycoprotein that is expressed in endothelial and epithelial cells as well as in some tumors. The investigators thought that the concentration of PlGF, which is an angiogenic actor, might be elev…

article 2003
Peritoneal Fluid Concentrations of Ciliary Neurotrophic Factor, a gp130 Cytokine, in Women with Endometriosis
Gynecologic and obstetric investigation ·doi:10.1159/000072694

Ciliary neurotrophic factor (CNTF) is a gp130 neuroregulatory cytokine belonging to the interleukin-6-type cytokine superfamily. Several lines of evidence suggest that the concentrations of interleukin-6 are elevated in the peritoneal fluid…

article 2003
Women with endometriosis have increased levels of placental growth factor in the peritoneal fluid compared with women with cystadenomas
Human Reproduction ·doi:10.1093/humrep/deg491

BACKGROUND: To assess the release of placental growth factor (PlGF) into peritoneal fluid in women with and without endometriosis, we measured its concentration with reference to disease stage, the presence of red endometriotic lesions and …

article 2001
Increased concentrations of cathepsin D in peritoneal fluid from women with endometriosis
Molecular human reproduction ·doi:10.1093/molehr/7.5.459

To assess the release of the proteolytic enzyme cathepsin D in endometriosis, concentrations in peritoneal fluid and serum were measured by ELISA in 54 women with (n = 33) and without (n = 21) endometriosis. Surgery was scheduled in either …

article 2001
Secretory leukocyte protease inhibitor in ovarian endometriomas following GnRH agonist therapy
Obstetrics and gynecology ·doi:10.1016/s0029-7844(00)01200-x

OBJECTIVE: To determine whether expression of secretory leukocyte protease inhibitor is affected in tissue and peritoneal fluid of women with ovarian endometriomas treated with GnRH analogues. METHODS: In 32 women with endometriomas (17 unt…

article 2001
Secretory Leukocyte Protease Inhibitor in Ovarian Endometriomas Following GnRH Agonist Therapy
·doi:10.1097/00006250-200104000-00015

In Brief Objective To determine whether expression of secretory leukocyte protease inhibitor is affected in tissue and peritoneal fluid of women with ovarian endometriomas treated with GnRH analogues. Methods In 32 women with endometriomas …

article 1999
Expression of secretory leukocyte protease inhibitor in women with endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(99)00381-7

ObjectiveTo explore endometriosis-related molecules in patients with use of differential display analysis.DesignProspective study.SettingNagoya City University Medical School, Nagoya, Japan.Patient(s)Women with endometriosis (n = 27) and wi…